academic article

• Association of Anticoagulant Choice on mortality in the Primary Treatment of Non-Cancer Venous Thromboembolism: Medicare 2011-2018..  American journal of epidemiology.  2024
• Venous thromboembolism mortality and trends in older US adults, 2011-2019..  American journal of hematology.  98:1364-1373. 2023
• Autoimmune disease and risk of postpartum venous thromboembolism..  Research and practice in thrombosis and haemostasis.  7:-. 2023
• Incidence and Risk Factors of Pulmonary Hypertension After Venous Thromboembolism: An Analysis of a Large Health Care Database..  Journal of the American Heart Association.  11:-. 2022
• Risk Factors for Dementia in Patients With Atrial Fibrillation..  The American journal of cardiology.  48-52. 2022
• Sex differences in treatment strategy and adverse outcomes among patients 75 and older with atrial fibrillation in the MarketScan database..  BMC cardiovascular disorders.  21:-. 2021
• Inpatient Versus Outpatient Acute Venous Thromboembolism Management: Trends and Postacute Healthcare Utilization From 2011 to 2018..  Journal of the American Heart Association.  10:-. 2021
• Claims-Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism..  Journal of the American Heart Association.  10:-. 2021
• Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis..  Research and practice in thrombosis and haemostasis.  5:-. 2021
• Association of Type of Antidepressant Initiation with Bleeding Risk in Atrial Fibrillation Patients Taking Oral Anticoagulants..  Drugs - real world outcomes.  8:383-391. 2021
• Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding..  Research and practice in thrombosis and haemostasis.  5:-. 2021
• Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association..  Circulation.  143:e254-e743. 2021
• Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association.  Circulation.  2021
• Weight change over 9 years and subsequent risk of venous thromboembolism in the ARIC cohort..  International journal of obesity (2005).  44:2465-2471. 2020
• Impact of oral anticoagulation choice on healthcare utilization for the primary treatment of venous thromboembolism..  Vascular medicine (London, England).  25:549-556. 2020
• Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation..  Journal of the American Heart Association.  9:-. 2020
• Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial Fibrillation..  The American journal of medicine.  133:e554-e567. 2020
• Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation..  JAMA internal medicine.  180:245-253. 2020
• Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without Hypogonadism..  JAMA internal medicine.  180:190-197. 2020
• Diagnosed Sleep Apnea and Cardiovascular Disease in Atrial Fibrillation Patients: The Role of Measurement Error from Administrative Data..  Epidemiology (Cambridge, Mass.).  30:885-892. 2019
• Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation..  PloS one.  14:-. 2019
• Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017..  Research and practice in thrombosis and haemostasis.  3:668-673. 2019
• Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolism..  British journal of haematology.  185:903-911. 2019
• Geographic Disparities in the Incidence of Stroke among Patients with Atrial Fibrillation in the United States..  Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.  28:890-899. 2018
• A new model to predict ischemic stroke in patients with atrial fibrillation using warfarin or direct oral anticoagulants..  Heart rhythm.  16:820-826. 2018
• Oral anticoagulation therapy and subsequent risk of venous thromboembolism in atrial fibrillation patients..  Current medical research and opinion.  35:837-845. 2018
• Association of Oral Anticoagulant Type With Risk of Dementia Among Patients With Nonvalvular Atrial Fibrillation..  Journal of the American Heart Association.  7:-. 2018
• Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer..  Journal of the American College of Cardiology.  72:1913-1922. 2018
• A new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants..  PloS one.  13:-. 2018
• All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous Thromboembolism..  Thrombosis and haemostasis.  118:1637-1645. 2018
• Influence of Sociodemographic Factors and Provider Specialty on Anticoagulation Prescription Fill Patterns and Outcomes in Atrial Fibrillation..  The American journal of cardiology.  122:388-394. 2018
• Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation..  Journal of the American Heart Association.  7. 2018
• Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation..  Blood advances.  2:200-209. 2018
• Oral anticoagulants and liver injury: the threat of uncontrolled confounding..  Heart (British Cardiac Society).  104:-. 2018
• Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation..  BMC cardiovascular disorders.  17:-. 2017
• Outpatient Treatment of Deep Vein Thrombosis in the United States: The Reasons for Geographic and Racial Differences in Stroke Study..  Journal of hospital medicine.  12:826-830. 2017
• Sleep characteristics and risk of dementia and Alzheimer's disease: The Atherosclerosis Risk in Communities Study..  Alzheimer's & dementia : the journal of the Alzheimer's Association.  14:157-166. 2017
• Questions in the comparative effectiveness of dabigatran and warfarin in atrial fibrillation..  Journal of cardiology.  70:99-100. 2017
• Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation..  Heart (British Cardiac Society).  103:834-839. 2017
• Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation..  Journal of cardiology.  69:868-876. 2016
• Sleep Apnea, Sleep Duration and Brain MRI Markers of Cerebral Vascular Disease and Alzheimer's Disease: The Atherosclerosis Risk in Communities Study (ARIC)..  PloS one.  11:-. 2016
• Obstructive Sleep Apnea and 15-Year Cognitive Decline: The Atherosclerosis Risk in Communities (ARIC) Study..  Sleep.  39:309-16. 2016
• Association of amiodarone use with acute pancreatitis in patients with atrial fibrillation: a nested case-control study..  JAMA internal medicine.  175:449-50. 2015
• Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin..  Stroke.  45:2286-91. 2014
• A genome-wide association study of aging..  Neurobiology of aging.  32:2109.e15-28. 2011